Mesenchymal stromal cell therapy restores intestinal integrity and attentuates inflammation in a preterm piglet model of necrotizing enterocolitis

In brief

Preclinical study demonstrating that mesenchymal stromal cell therapy improves intestinal barrier integrity and reduces inflammatory response in a preterm piglet model of necrotizing enterocolitis. Findings suggest potential therapeutic application for this devastating neonatal condition affecting premature infants.

Written by the GCMD Library team from the article.